4//SEC Filing
Simpson Adam K. 4
Accession 0001209191-24-000844
CIK 0001786255other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:05 PM ET
Size
11.3 KB
Accession
0001209191-24-000844
Insider Transaction Report
Form 4
Icosavax, Inc.ICVX
Simpson Adam K.
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2024-01-02$1.04/sh+15,000$15,600→ 275,641 total - Sale
Common Stock
2024-01-02$15.67/sh−15,000$235,088→ 260,641 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-01-02−15,000→ 299,676 totalExercise: $1.04Exp: 2031-01-28→ Common Stock (15,000 underlying)
Holdings
- 129,032(indirect: By Trust)
Common Stock
- 129,032(indirect: By Trust)
Common Stock
- 531,576(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]The sales were effected pursuant to a Rule 10b5-1 instruction letter dated September 16, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.60 to $15.76. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]25% of the shares subject to the option vested on January 14, 2022, and 1/48th of the shares subject to the option vest monthly thereafter.
Documents
Issuer
Icosavax, Inc.
CIK 0001786255
Entity typeother
Related Parties
1- filerCIK 0001873839
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:05 PM ET
- Size
- 11.3 KB